Skip to main content
OpenTrials

Clinical trial condition

HER2+ Metastatic Breast Cancer (MBC)

Explore clinical trials studying HER2+ Metastatic Breast Cancer (MBC). Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

HER2+ Metastatic Breast Cancer (MBC) trial results

Completed

A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting

NCT01808573

Conditions
HER2+ Metastatic Breast Cancer (MBC)
Locations
  • Ironwood Cancer and Research Centers Chandler, Arizona, United States
  • Ironwood Cancer and Research Centers Gilbert, Arizona, United States
  • Ironwood Cancer and Research Centers Mesa, Arizona, United States
  • Ironwood Cancer and Research Centers Scottsdale, Arizona, United States
View all 252 locations
View Trial Details